Coverage of TMCR remains thin and only recently initiated. Stifel began coverage in August 2026 with a Buy rating and a $10 target, while William Blair initiated in September 2026 with an Outperform rating and an $8 fair value. The arithmetic mean of these two targets is $9. Some aggregators also list a third, more bullish target near $17.50, which would raise the average to roughly $12; that higher figure is reported but is harder to attribute to a specific firm. The result is an unusually wide spread between cautious and optimistic views.
William Blair pointed to the company's "early-mover advantage and the vast available critical mineral opportunities," while Stifel framed the royalty model as exposure to commodity upside with reduced operational risk. These rationales are directionally bullish but rest on a very small sample of analysts and on projects that are years from generating cash. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how recent technical signals align with the broader narrative.
Shares of TMCR recently traded near $2.00, toward the lower end of a 52-week range of roughly $1.70 to $21.38. Reaching the $9 target would require a gain of about 350%, a very large move by any standard. The company has a market capitalization of roughly $130 million and negative earnings per share (EPS), meaning it does not yet generate profits to support valuation.
A move toward the target would most plausibly depend on progress at the company's core asset—a 2.0% gross overriding royalty on the NORI polymetallic nodule project in the Clarion-Clipperton Zone of the Pacific Ocean—as well as the newly added Mesabi iron ore royalty and the associated $165 million financing. Because these are early-stage, long-dated interests, any re-rating would likely be driven by milestones and sentiment rather than near-term earnings.
The most durable reference points are the 52-week low near $1.70 and the prior high near $21.38. The stock has spent recent months well below its listing price, so there is substantial overhead supply between the current price and any higher target. The $2 level is a near-term psychological zone, while $5 and $10 would represent much larger round-number hurdles. Until the stock establishes higher lows and recovers lost ground, the long-term trend structure remains clearly bearish from a technical standpoint. From what I see, monitoring these levels closely remains essential.
Analyst targets typically reflect a roughly 12-month research horizon, though no explicit timeframe was disclosed for these early initiations, and for a pre-revenue royalty company the relevant catalysts may extend well beyond one year. Investors should watch closing of the Mesabi royalty and financing, further royalty acquisitions, NORI project and deep-sea mining permitting milestones, any progress toward first revenue, and future analyst initiations or revisions. Broader critical-minerals sentiment and commodity prices also matter for a royalty vehicle.
In my experience following names like TMCR, Tickeron’s AI Daily Buy/Sell Signals provide a practical way to stay on top of shifting market conditions. The tool uses artificial intelligence to monitor thousands of stocks and ETFs in real time, generating Buy, Sell, or Hold signals based on technical behavior and broader trends. It helps me screen for opportunities and track positions without relying solely on manual analysis, which can be especially useful when coverage is thin and volatility is high.
The $9 central target is the average of the two clearly attributable analyst targets—Stifel's $10 and William Blair's $8—and sits roughly 350% above the recent share price, with some aggregators citing an even higher figure near $17.50. Support comes from the royalty model, the critical-minerals narrative, and portfolio expansion via the Mesabi royalty and financing. Against that, TMCR remains pre-revenue, heavily concentrated in a speculative deep-sea mining asset, and is trading far below its post-listing high. Given the thin coverage and wide dispersion of views, the $9 target represents an ambitious, multi-year scenario rather than a near-term expectation, and investors should monitor financing and project milestones closely before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TMCR saw its Momentum Indicator move below the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 9 similar instances where the indicator turned negative. In 9 of the 9 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TMCR entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for TMCR just turned positive on October 22, 2026. Looking at past instances where TMCR's MACD turned positive, the stock continued to rise in 1 of 1 cases over the following month. The odds of a continued upward trend are 90%.
Following a +17.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMCR advanced for three days, in 11 of 15 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
TMCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.004) is normal, around the industry mean (6.813). P/E Ratio (-7.076) is within average values for comparable stocks, (-0.701). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.026). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (283.864).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. TMCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OtherMetalsMinerals